Swiss National Bank’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $721K | Hold |
212,100
| – | – | ﹤0.01% | 2251 |
|
|
2025
Q1 | $851K | Sell |
212,100
-6,700
| -3% | -$26.9K | ﹤0.01% | 2199 |
|
|
2024
Q4 | $1.42M | Hold |
218,800
| – | – | ﹤0.01% | 2048 |
|
|
2024
Q3 | $1.21M | Hold |
218,800
| – | – | ﹤0.01% | 2128 |
|
|
2024
Q2 | $1.22M | Buy |
218,800
+4,800
| +2% | +$26.8K | ﹤0.01% | 2068 |
|
|
2024
Q1 | $1.44M | Sell |
214,000
-14,500
| -6% | -$97.3K | ﹤0.01% | 2027 |
|
|
2023
Q4 | $2.08M | Buy |
228,500
+34,600
| +18% | +$316K | ﹤0.01% | 1802 |
|
|
2023
Q3 | $1.07M | Buy |
193,900
+17,000
| +10% | +$93.8K | ﹤0.01% | 2208 |
|
|
2023
Q2 | $1.51M | Buy |
176,900
+31,300
| +21% | +$267K | ﹤0.01% | 2067 |
|
|
2023
Q1 | $1.34M | Sell |
145,600
-17,000
| -10% | -$156K | ﹤0.01% | 2077 |
|
|
2022
Q4 | $1.66M | Buy |
162,600
+4,500
| +3% | +$45.9K | ﹤0.01% | 2018 |
|
|
2022
Q3 | $2.33M | Hold |
158,100
| – | – | ﹤0.01% | 1765 |
|
|
2022
Q2 | $1.7M | Buy |
+158,100
| New | +$1.7M | ﹤0.01% | 2038 |
|